NIH Health Information for Patients and the General Public

The National Institutes of Health maintains a broad portfolio of patient-facing and public health information resources, spanning condition-specific guidance, clinical trial access, and peer-reviewed research databases. These resources are produced and curated by 27 institutes and centers, each focused on a defined disease or research domain. Understanding how these resources are organized, who they serve, and how to navigate them is essential for patients, caregivers, and health professionals seeking evidence-based information outside a clinical encounter. The NIH health information ecosystem operates as an interconnected set of platforms governed by federal public access and data-sharing policies.

Definition and scope

NIH health information for patients and the general public refers to the body of federally produced, publicly accessible educational and clinical content that NIH makes available without charge through official digital platforms. This content is distinct from NIH's primary research output — it is curated, translated, or summarized specifically to be accessible to non-specialist audiences.

The scope spans four major categories:

1. Consumer health encyclopedias — Plain-language condition and symptom summaries, drug information, and wellness guidance, primarily hosted on MedlinePlus, the National Library of Medicine's flagship consumer resource.
2. Clinical trial listings — Public-facing records of active, recruiting, completed, and terminated studies registered in ClinicalTrials.gov, a database mandated under the FDA Modernization Act and maintained by NLM.
3. Research publication access — Peer-reviewed literature made available through PubMed and associated research databases, including full-text articles deposited under NIH's public access policy.
4. Institute-specific disease portals — Condition-focused pages produced by individual institutes such as the National Cancer Institute (NCI), the National Institute of Mental Health (NIMH), and the National Institute on Aging (NIA), each following NIH editorial standards.

This body of content is governed by the NIH open access and public access policy, which requires NIH-funded researchers to deposit final peer-reviewed manuscripts into PubMed Central within 12 months of publication — a requirement formally codified under the NIH Reform Act of 2006 and reinforced by a 2023 National Science and Technology Council policy memo directing all major federal funding agencies to eliminate the 12-month embargo.

How it works

NIH health information reaches patients and the public through a layered production and distribution model. At the base layer, NIH-funded extramural and intramural researchers generate primary findings. A separate editorial and communications function within each institute translates those findings into patient-accessible formats — reviewed by medical officers and, in many cases, external scientific advisors before publication.

MedlinePlus serves as the central consumer-facing portal. Administered by the National Library of Medicine, it indexes more than 1,000 health topic pages in English and Spanish, links to the Drug Information Portal covering over 53,000 substances, and connects users to genetics information through MedlinePlus Genetics (formerly Genetics Home Reference). Each topic page aggregates links from NIH institutes, the Centers for Disease Control and Prevention, the Food and Drug Administration, and peer-reviewed journals — with editorial curation to exclude non-authoritative sources.

ClinicalTrials.gov, also operated by NLM, holds registration records for more than 470,000 studies as of its public database, making it the world's largest clinical trial registry. Patients use it to identify recruiting studies by condition, location, age eligibility, and intervention type.

NIH News in Health and institute-specific news bureaus distribute findings in newsletter and web article formats, subject to science communication review rather than peer review. These are explicitly positioned as educational, not diagnostic.

The distinction between patient information and clinical guidance is maintained structurally: NIH does not publish clinical practice guidelines. That function resides with bodies such as the Agency for Healthcare Research and Quality (AHRQ) or professional medical societies. NIH's role is upstream — producing and disseminating the evidence base from which guidelines are later derived.

Common scenarios

Patients and caregivers encounter NIH health information resources across a predictable set of situations:

• Diagnosis research — A patient newly diagnosed with a condition searches MedlinePlus for plain-language explanations of pathophysiology, treatment categories, and specialist referral guidance.
• Clinical trial eligibility — A patient with a treatment-resistant condition searches ClinicalTrials.gov for Phase II or Phase III recruiting trials at the NIH Clinical Center in Bethesda, Maryland, or at affiliated academic medical centers.
• Medication verification — A caregiver cross-references a prescribed drug on the NLM Drug Information Portal to confirm interactions, contraindications, and FDA approval status.
• Genetic condition research — A family with a suspected heritable disorder uses MedlinePlus Genetics to locate condition summaries linked to OMIM (Online Mendelian Inheritance in Man) entries and genetic testing laboratory directories.
• Research literacy — A patient seeking to read primary literature uses PubMed to locate free full-text articles deposited in PubMed Central, particularly for NIH-funded studies subject to the public access mandate.

Decision boundaries

Understanding what NIH public health information is — and is not — prevents misuse. Three structural boundaries define the resource:

NIH information vs. clinical advice: NIH-produced consumer content provides general, population-level descriptions of conditions and treatments. It does not constitute individualized medical advice, prescribing guidance, or a substitute for a licensed clinician's judgment. This boundary is maintained editorially across all NIH platforms.

MedlinePlus vs. PubMed: MedlinePlus is designed for general audiences with no assumed scientific training; its content is curated and simplified. PubMed indexes primary scientific literature for researchers and clinicians; its content assumes familiarity with study design, statistical methods, and clinical terminology. A general user who navigates from MedlinePlus to a linked PubMed abstract has crossed from consumer content into technical literature without a structured bridge — a distinction that health literacy advocates, including those working with the NIH All of Us Research Program, have identified as a persistent navigation challenge.

Federally produced content vs. linked external content: MedlinePlus links to content from non-NIH sources including medical societies and academic health centers. Those external pages are not produced, reviewed, or maintained by NIH; their inclusion reflects editorial judgment about source quality at the time of curation, not a federal endorsement of their accuracy at any future date.

For users seeking broader context on NIH's organizational scope, the NIH main resource index provides navigation across the full range of institutes, research programs, and public access tools covered in this reference network.